The Effect of Mycophenolate Mofetil Dose per Kilogram on Clinical Outcomes of Allogeneic Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide

被引：0
|
作者：
Elmariah, Hany [1 ]
Laborde, Jose [2 ]
Kim, Jongphil [2 ]
Gonzalez, Rebecca [3 ]
DiMaggio, Elizabeth [3 ]
Nishihori, Taiga [1 ]
Mishra, Asmita [1 ]
Perez, Lia Elena [1 ]
Liu, Hien [1 ]
Khimani, Farhad [1 ]
Ochoa-Bayona, Jose [1 ]
Faramand, Rawan [1 ]
Baluch, Aliyah [4 ]
Nieder, Michael L. [1 ]
Lazaryan, Aleksandr [1 ]
Sullivan, Daniel [1 ]
Pidala, Joseph A. [1 ]
Bejanyan, Nelli [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Blood & Marrow Transplantat & Cellular Immunother, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Biostat, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Pharm, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, IHM ID, Tampa, FL USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
278
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [21] Serum Interleukin-6 Predicts the Outcomes of Allogeneic Transplant with Post-Transplant Cyclophosphamide
    Greco, Raffaella
    Lorentino, Francesca
    Nitti, Rosamaria
    Stanghellini, Maria Teresa Lupo
    Xue, Elisabetta
    Giglio, Fabio
    Clerici, Daniela
    Piemontese, Simona
    Assanelli, Andrea
    Marktel, Sarah
    Corti, Consuelo
    Bernardi, Massimo
    Ciceri, Fabio
    Peccatori, Jacopo
    BONE MARROW TRANSPLANTATION, 2018, 53 : 60 - 61
  • [22] Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
    Zhao, Chenchen
    Bartock, Matthew
    Jia, Bei
    Shah, Neal
    Claxton, David F.
    Wirk, Baldeep
    Rakszawski, Kevin L.
    Nickolich, Myles S.
    Naik, Seema G.
    Rybka, Witold B.
    Ehmann, W. Christopher C.
    Hohl, Raymond J.
    Valentin, Jessica
    Bernas-Peterson, Michelle
    Gerber, Emily M.
    Zimmerman, Michele
    Mierski, Joseph A.
    Mineishi, Shin
    Zheng, Hong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [23] Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
    Chenchen Zhao
    Matthew Bartock
    Bei Jia
    Neal Shah
    David F. Claxton
    Baldeep Wirk
    Kevin L. Rakszawski
    Myles S. Nickolich
    Seema G. Naik
    Witold B. Rybka
    W Christopher C. Ehmann
    Raymond J. Hohl
    Jessica Valentin
    Michelle Bernas-Peterson
    Emily M. Gerber
    Michele Zimmerman
    Joseph A. Mierski
    Shin Mineishi
    Hong Zheng
    Journal of Hematology & Oncology, 15
  • [24] Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation
    Nakamae, Hirohisa
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [25] Assessment of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplant When Comparing Treatment with and without Post-Transplant Cyclophosphamide
    Nurse, Daniel P.
    Wei, Wei
    Burns, Amanda
    Farinella, Joseph
    Jagadeesh, Deepa
    Dean, Robert M.
    Hanna, Rabi
    Rotz, Seth J.
    Gerds, Aaron T.
    Brunstein, Claudio
    Kalaycio, Matt
    Sauter, Craig S.
    Hamilton, Betty K.
    Sobecks, Ronald
    BLOOD, 2024, 144 : 7383 - 7384
  • [26] Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide
    Daniel J. Ikeda
    Zachariah DeFilipp
    Kerry Collier
    Yi-Bin Chen
    Bimalangshu R. Dey
    Areej El-Jawahri
    Matthew J. Frigault
    Mark B. Leick
    Steven L. McAfee
    Richard A. Newcomb
    Paul V. O’Donnell
    Thomas R. Spitzer
    Bone Marrow Transplantation, 2024, 59 (1) : 131 - 133
  • [27] Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide
    Ikeda, Daniel J.
    DeFilipp, Zachariah
    Collier, Kerry
    Chen, Yi-Bin
    Dey, Bimalangshu R.
    El-Jawahri, Areej
    Frigault, Matthew J.
    Leick, Mark B.
    McAfee, Steven L.
    Newcomb, Richard A.
    O'Donnell, Paul V.
    Spitzer, Thomas R.
    BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 131 - 133
  • [28] Incidence and risk factors for hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation
    Gomez Hernando, M.
    Pedraza, A.
    Quintana, L.
    Carcelero, E.
    Riu, G.
    Monge, I.
    Domenech, A.
    Solano, M. T.
    Suarez-Lledo, M.
    Martinez-Cibrian, N.
    Rosinol, L.
    Gutierrez-Garcia, G.
    Carreras, E.
    Esteve, J.
    Urbano-Ispizua, A.
    Fernandez Aviles, F.
    Martinez, C.
    Rovira, M.
    Salas, M. Q.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 193 - 193
  • [29] Validation of Different Prognostic Scores in Allogeneic Hematopoietic Cell Transplantation in the Post-Transplant Cyclophosphamide Era
    Salas, Maria Queralt
    Rodriguez-Lobato, Luis Gerardo
    Suarez-Lledo, Maria
    Martinez-Cibrian, Nuria
    Solano, Teresa
    Arcarons, Jordi
    Llobet, Noemi
    Domenech, Ariadna
    Pedraza, Alexandra
    Nomdedeu, Meritxell
    Cid, Joan
    Lozano, Miquel
    Rosinol, Laura
    Fernandez-Aviles, Francesc
    Gutierrez-Garcia, Gonzalo
    Carreras, Enric
    Esteve, Jordi
    Urbano-Ispizua, Alvaro
    Rovira, Montserrat
    Martinez, Carmen
    BLOOD, 2021, 138
  • [30] Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory study
    Kasudhan, Kripa Shanker
    Patil, Amol N.
    Jandial, Aditya
    Khadwal, Alka
    Prakash, Gaurav
    Jain, Arihant
    Bhurani, Dinesh
    Ahmed, Rayaz
    Agrawal, Narendra
    Singh, Reema
    Sachdeva, Man Updesh Singh
    Varma, Neelam
    Das, Reena
    Verma Attri, Savita
    Malhotra, Samir
    Majhail, Navneet S.
    Malhotra, Pankaj
    Lad, Deepesh P.
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2679 - 2685
12345